A study published in PubMed highlights the treatment of pleomorphic giant cell carcinoma of the prostate using Lutetium-177 PSMA. This research contributes to the understanding of targeted therapies for rare prostate cancer variants.
pleomorphic giant cell carcinoma of the prostate treated with lutetium 177 psma
Original title: “Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium-177 PSMA.”